Fundoplication versus medical management of gastroesophageal reflux disease: Systematic review and meta-analysis

Surgical Endoscopy

Volumn 28, Issue 1, 2014, Pages 143-155

  Rickenbacher, Nadja ^a,b,c   Kötter, Thomas ^b   Kochen, Michael M ^d   Scherer, Martin ^c   Blozik, Eva ^b,c,d  

^a FEDERAL OFFICE OF PUBLIC HEALTH   (Switzerland)

^b UNIVERSITY OF LÜBECK   (Germany)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Anti ulcer agents; Fundoplication; Gastroesophageal reflux; Meta analysis; Proton pump inhibitors; Review

Indexed keywords

ANTACID AGENT; METOCLOPRAMIDE; OMEPRAZOLE; RANITIDINE; SUCRALFATE;

ABDOMINAL PAIN; ARTICLE; BLOATING; COMPARATIVE EFFECTIVENESS; CONSTIPATION; DIARRHEA; DRUG USE; DYSPHAGIA; FLATULENCE; FOLLOW UP; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMAN; INDIGESTION; LAPAROSCOPIC SURGERY; META ANALYSIS; OUTCOME ASSESSMENT; PATIENT SATISFACTION; PEROPERATIVE COMPLICATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); STOMACH FUNDOPLICATION; SURGICAL MORTALITY; SYSTEMATIC REVIEW;

ADULT; ANTI-ULCER AGENTS; FUNDOPLICATION; GASTROESOPHAGEAL REFLUX; HUMANS; LAPAROSCOPY; PROTON PUMP INHIBITORS; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 84892958676     PISSN: 09302794     EISSN: 14322218     Source Type: Journal    
DOI: 10.1007/s00464-013-3140-z     Document Type: Article

References (33)

1. Dent J, El-Serag H, Wallander MA, Johansson S (2005) Epidemiology of gastrooesoghageal reflux disease: a systematic review. Gut 54: 710-717
2. Moller Hansen J, Wildner-Christensen M, Schaffalitzky de Muckadell OB (2009) Gastroesophageal reflux symptoms in a Danish Population: a prospective follow-up analysis of symptoms, quality-of-life, and health-care use. Am J Gastroenterol 104: 2394-2403
3. Katz PO, Gerson LB, Vela MF (2013) Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol 108: 308-328
4. Khalili H, Huang ES, Jacobson BC, Camargo CA, Feskanich D, Chan AT (2012) Use of proton pump inhibitors and risk of hip fracture in relation to dietary and lifestyle factors: a prospective cohort study. BMJ 344:e372
5. Gray SL, LACroix AZ, Larson J, Robbins J, Cauley JA, Manson JE, Chen Z (2010) Proton pump inhibitor use, hip fracture, and change in bone mineral density in postmenopausal women: results from the Women's Health Initiative. Arch Int Med 170: 765-771
6. Neufel M, Graham A (2007) Levels of evidence available for techniques in antireflux surgery. Dis Esophagus 20: 161-167
7. Koch OO, Kaindlstorfer A, Antoniou SA, Luketina RR, Emmanuel K, Pointner R (2013) Comparison of results from a randomized trial 1 year after laparoscopic Nissen and Toupet fundoplications. Surg Endosc 27(7): 2383-2390
8. Behar J, Sheahan DG, Biancani P, Spiro HM, Storer EH (1975) Medical and surgical management of reflux esophagitis: a 38-month report of a prospective clinical trial. N Eng J Med 293: 263-268
9. Spechler SJ (1992) Comparison of medical and surgical therapy for complicated gastroesophageal reflux disease in veterans. The Department of Veterans Affairs Gastroesophageal Reflux Disease Study Group. N Engl J Med 326: 786-792
10. Allgood PC, Bachmann M (2000) Medical or surgical treatment for chronic gastrooesophageal reflux? A systematic review of published evidence of effectiveness. Eur J Surg 166: 713-721
11. Urbach DR, Horvath KD, Baxter NN, Jobe BA, Madan AK, Pryor AD, Khaitan L, Torquati A, Brower ST, Trus TL, Schwaitzberg S (2007) A research agenda for gastrointestinal and endoscopic surgery. Surg Endosc 21: 1518-1525
12. Frazzoni M, Piccoli M, Conigliaro R, Manta R, Frazzoni L, Melotti G (2013) Refractory gastroesophageal reflux disease as diagnosed by impedance-pH monitoring can be cured by laparoscopic fundoplication. Surg Endosc 27(8): 2940-2946
13. Juni P, AltmanDG,EggerM(2001) Systematic reviews in health care: assessing the quality of controlled clinical trials. BMJ 323: 42-46
14. Higgins JPT, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327: 557-560
15. Spechler SJ, Lee E, Ahnen D, Goyal RK, Hirano I, Ramirez F, Raufman JP, Sampliner R, Schnell T, Sontag S, Vlahcevic ZR, Young R, Williford W (2001) Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: follow-up of a randomized con-trolled trial. JAMA 285: 2331-2338
16. Lundell L, Miettinen P, Myrvold HE, Pedersen SA, Liedman B, Hatlebakk JG, Julkonen R, Levander K, Carlsson J, Lamm M, Wiklund I (2001) Continued (5-year) follow-up of a randomized clinical study comparing antireflux surgery and omeprazole in gastroesophageal reflux disease. J Am Coll Surg 192: 172-179
17. Lundell L, Miettinen P, Myrvold HE, Hatlebakk JG, Wallin L, Engström C, Julkunen R, Montgomery M, Malm A, Lind T, Walan A, Nordic GERD Study Group (2009) Comparison of outcomes twelve years after antireflux surgery or omeprazole maintenance therapy for reflux esophagitis. Clin Gastroenterol Hepatol 7: 1292-1298
18. Mahon D, Rhodes M, Decadt B, Hindmarsh A, Lowndes R, Beckingham I, Koo B, Newcombe RG (2005) Randomized clinical trial of laparoscopic Nissen fundoplication compared with proton pump inhibitors for treatment of chronic gastroesophageal reflux. Br J Surg 92: 695-699
19. Mehta S, Bennett J, Mahon D, Rhodes M (2006) Prospective trial of laparoscopic Nissen fundoplication versus proton pump inhibitor therapy for gastroesophageal reflux disease: seven-year follow-up. J Gastrointest Surg 10: 1312-1317
20. Anvari M, Allen C, Marshall J, Armstrong D, Goeree R, Ungar W, Goldsmith C (2006) A randomized controlled trial of laparoscopic Nissen fundoplication versus proton pump inhibitors for treatment of patients with chronic gastroesophageal reflux disease: one-year follow-up. Surg Innov 13: 238-249
21. Anvari M, Allen C, Marshall J, Armstrong D, Goeree R, Ungar W, Goldsmith C (2011) A randomized controlled trial of laparoscopic Nissen fundoplication versus proton pump inhibitors for the treatment of patients with chronic gastroesophageal reflux disease (GERD): 3-year outcomes. Surg Endosc 25: 2547-2554
22. Grant AM, Wileman SM, Ramsay CR, Mowat NA, Krukowski ZH, Heading RC, Thursz MR, Campbell MK, REFLUX Trial Group (2008) Minimal access surgery compared with medical management for chronic gastro-oesophageal reflux disease: UK collaborative randomised trial. BMJ 337:a2664
23. Grant AM, Cotton SC, Boachie C, Ramsay CR, Krukowski ZH, Heading RC, Campbell MK, REFLUX Trial Group (2013) Minimal access surgery compared with medical management for gastro-oesophageal reflux disease: five year follow-up of a randomised controlled trial (REFLUX). BMJ 346:f1908
24. Lundell L, Attwood S, Ell C, Fiocca R, Galmiche JP, Hatlebakk J, Lind T, Junghard O, LOTUS trial collaborators (2008) Comparing laparoscopic antireflux surgery with esomeprazole in the management of patients with chronic gastro-oesophageal reflux disease: a 3-year interim analysis of the LOTUS trial. Gut 57: 1207-1213
25. Galmiche JP, Hatlebakk J, Attwood S, Ell C, Fiocca R, Eklund S, Långström G, Lind T, Lundell L, LOTUS Trial Collaborators (2011) Laparoscopic antireflux surgery vs. esomeprazole treatment for chronic GERD: the LOTUS randomized clinical trial. JAMA 305: 1969-1977
26. Egger M (2001) Systematic reviews in health care: meta-analysis in context. BMJ, London
27. Higgins JPT, Green S (2009) Cochrane handbook for systematic reviews of interventions, version 5.0.2. at www.cochranehandbook. org. Accessed 18 Mar 2013
28. Noble LJ, Dalzell AM, El-Matary W (2012) The relationship between percutaneous endoscopic gastrostomy and gastrooesophageal reflux disease in children: a systematic review. Surg Endosc 26: 2504-2512
29. Wileman SM, McCann S, Grant AM, Krukowski ZH, Bruce J (2010) Medical versus surgical management for gastro-oesophageal reflux disease (GORD) in adults. Cochrane Database Syst Rev 17(3):CD003243
30. Miholic J, Hafez J, Lenglinger J, Wrba F, Wischin C, Schütz K, Hudec M (2012) Hiatal hernia, Barrett's esophagus, and longterm symptom control after laparoscopic fundoplication for gastroesophageal reflux. Surg Endosc 26: 3225-3231
31. Ip S, Tatsioni A, Conant A, Karagozian R, Fu L, Chew P, Raman G, Lau J, Bonis P (2009) Predictors of clinical outcomes following fundoplication for gastroesophageal reflux disease remain insufficiently defined: a systematic review. Am J Gastroenterol 104: 752
32. NICE (2004) Dyspepsia: managing dyspepsia in adults in primary care: clinical guidelines, CG17. at http://www.nice.org.uk/nicemedia/pdf/ CG017fullguideline.pdf. Accessed 18 Mar 2013
33. Stefanidis D, Hope WW, Kohn GP, Reardon PR, Richardson WS, Fanelli RD, SAGES Guidelines Committee (2010) Guidelines for surgical treatment of gastroesophageal reflux disease. Surg Endosc 24: 2647-2669